SCHEMBL5490427

SCHEMBL5490427

Cc1cc(-c2ccccc2C(N)=O)ccc1C(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCAT2 O15382 1/20 0.51
▸ CHEK1 O14757 1/20 0.46
▸ ALOX5AP P20292 1/20 0.45
▸ FEN1 P39748 1/20 0.45
▸ IRAK4 Q9NWZ3 2/20 0.43
▸ CTSA P10619 2/20 0.42
▸ SLC6A2 P23975 1/20 0.41
▸ SLC6A4 P31645 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ MKNK1 Q9BUB5 1/20 0.40
▸ MKNK2 Q9HBH9 1/20 0.40
▸ KEAP1 Q14145 1/20 0.40
▸ NFE2L2 Q16236 1/20 0.40
▸ MCL1 Q07820 1/20 0.39
▸ TGFBR1 P36897 1/20 0.39
▸ KLKB1 P03952 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ PLA2G10 O15496 2/20 0.38
▸ PLA2G2A P14555 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27758304 0.83 BCAT2 (0.59) BCAT2CHEK1ALOX5APFEN1CTSA
SCHEMBL27707954 0.77 BCAT2 (0.56) BCAT2CHEK1ALOX5APFEN1CTSA
SCHEMBL5724410 0.77 BCAT2 (0.56) BCAT2CHEK1ALOX5APFEN1CTSA
SCHEMBL2563193 0.76 BCAT2 (0.65) BCAT2CHEK1ALOX5APFEN1IRAK4
SCHEMBL29493488 0.76 BCAT2 (0.53) BCAT2IRAK4KEAP1NFE2L2HSP90AA1
SCHEMBL12543763 0.76 BCAT2 (0.59) BCAT2CHEK1ALOX5APFEN1IRAK4
SCHEMBL5878337 0.75 BCAT2 (0.87) BCAT2CHEK1ALOX5APFEN1SLC6A4
SCHEMBL31621279 0.74 SLC6A2 (0.64) BCAT2CHEK1ALOX5APFEN1SLC6A2
SCHEMBL31621280 0.74 SLC6A2 (0.64) BCAT2CHEK1ALOX5APFEN1SLC6A2
SCHEMBL25139064 0.74 BCAT2 (0.49) BCAT2CHEK1ALOX5APFEN1IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC. (US) 2007-09-26 — — EP claimed
WO-2006039718-A2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2006-04-13 — — WO claimed
WO-2016004272-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2016-01-07 — — WO disclosed
Send feedback